CBD is considered a medicine in Finland and any CBD-infused product, whether for human or animal use, would be classified as a medicinal product. This report provides a comprehensive overview of the regulatory landscape of CBD in Finland ...
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
